Global Nasal Drug Delivery Technology to 2025 - Featuring 3M, Aptargroup & Novartis International Among Others - ResearchAndMarkets.com
Global Nasal Drug Delivery Technology to 2025 - Featuring 3M, Aptargroup & Novartis International Among Others - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Nasal Drug Delivery Technology - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.
The Nasal Drug Delivery Technology market worldwide is projected to grow by US$25.4 Billion, driven by a compounded growth of 6.2%.
Nasal Sprays, one of the segments analyzed and sized in this study, displays the potential to grow at over 7.3%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$39.9 Billion by the year 2025, Nasal Sprays will bring in healthy gains adding significant momentum to global growth.
Representing the developed world, the United States will maintain a 7.1% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$1.1 Billion to the region's size and clout in the next 5 to 6 years. Over US$1.2 Billion worth of projected demand in the region will come from the rest of the European markets. In Japan, Nasal Sprays will reach a market size of US$3.2 Billion by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 5.9% over the next couple of years and add approximately US$4.4 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.
Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.
Competitors identified in this market include:
- 3M Company
- Aegis Therapeutics LLC
- Aptargroup, Inc.
- AstraZeneca PLC
- GlaxoSmithKline PLC
- Johnson & Johnson
- Merck & Co., Inc.
- Novartis International AG
-
Pfizer, Inc.
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Global Competitor Market Shares
- Nasal Drug Delivery Technology Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
IV. COMPETITION
V. CURATED RESEARCH
For more information about this report visit https://www.researchandmarkets.com/r/jwdkpp
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
